Oneness Biotech Co., Ltd. (LUX: ONES)
Luxembourg
· Delayed Price · Currency is EUR · Price in USD16.10
0.00 (0.00%)
At close: Dec 3, 2024
Oneness Biotech Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -1,259 | -1,313 | 359.98 | -403.3 | -241.9 | -322.21 | Upgrade
|
| Depreciation & Amortization | 465.24 | 445.54 | 491.23 | 195.07 | 191.3 | 65.31 | Upgrade
|
| Other Amortization | 3.46 | 3.46 | 3.41 | 2.27 | 1.32 | 0.83 | Upgrade
|
| Loss (Gain) From Sale of Assets | 5.01 | -0.26 | - | - | - | 0 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | 0.63 | -6.19 | - | 6.19 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.32 | 0.03 | -0.11 | -0.97 | 11.77 | -35.33 | Upgrade
|
| Loss (Gain) on Equity Investments | 301.28 | 498.78 | -90.02 | -280.31 | -485.93 | 43.98 | Upgrade
|
| Stock-Based Compensation | 52.54 | 44.43 | 20.34 | 21.71 | 31.9 | 22.42 | Upgrade
|
| Other Operating Activities | 51.54 | -96.74 | -697.48 | -228.9 | 47.07 | -0.07 | Upgrade
|
| Change in Accounts Receivable | -12.3 | -12.94 | 1.25 | 453.79 | -12.21 | 0.89 | Upgrade
|
| Change in Inventory | -15.22 | -19.35 | -31.42 | -31.13 | -4.78 | 1.74 | Upgrade
|
| Change in Accounts Payable | 0.23 | 0.29 | -0.33 | -39.22 | 50.74 | -0.14 | Upgrade
|
| Change in Unearned Revenue | 23.31 | 30.08 | -1,010 | - | 555.52 | - | Upgrade
|
| Change in Other Net Operating Assets | 33.66 | -2.63 | 71.02 | 28.29 | 13.33 | 3.12 | Upgrade
|
| Operating Cash Flow | -349.58 | -422.18 | -881 | -288.89 | 158.14 | -213.25 | Upgrade
|
| Capital Expenditures | -65.86 | -90.06 | -87.35 | -95.35 | -44.82 | -44.46 | Upgrade
|
| Cash Acquisitions | - | - | - | - | - | 79.51 | Upgrade
|
| Sale (Purchase) of Intangibles | -1.29 | -0.86 | -1.84 | -4.95 | -108.45 | -2.82 | Upgrade
|
| Investment in Securities | 237.32 | -4,747 | 5,797 | 156.12 | -5,555 | 210.6 | Upgrade
|
| Other Investing Activities | 7.73 | 18.11 | 27.67 | 3.2 | 4.89 | 0.11 | Upgrade
|
| Investing Cash Flow | 177.9 | -4,820 | 5,736 | 59.54 | -5,703 | 243.49 | Upgrade
|
| Long-Term Debt Repaid | - | -14.22 | -13.38 | -24.58 | -24.06 | -14.32 | Upgrade
|
| Net Debt Issued (Repaid) | -31.17 | -14.22 | -13.38 | -24.58 | -24.06 | -14.32 | Upgrade
|
| Issuance of Common Stock | 72.17 | 257.01 | 344.12 | 516.25 | 5,620 | - | Upgrade
|
| Common Dividends Paid | - | -39.09 | - | - | - | - | Upgrade
|
| Other Financing Activities | -0.01 | 182.88 | 121.13 | -147 | - | - | Upgrade
|
| Financing Cash Flow | 40.99 | 386.58 | 451.87 | 344.67 | 5,596 | -14.32 | Upgrade
|
| Foreign Exchange Rate Adjustments | 27.34 | 12.89 | 15.44 | -0 | 0.01 | -0.02 | Upgrade
|
| Net Cash Flow | -103.35 | -4,842 | 5,322 | 115.32 | 51.08 | 15.89 | Upgrade
|
| Free Cash Flow | -415.44 | -512.23 | -968.35 | -384.24 | 113.32 | -257.71 | Upgrade
|
| Free Cash Flow Margin | -370.28% | -590.25% | -90.88% | -584.26% | 272.37% | -1912.52% | Upgrade
|
| Free Cash Flow Per Share | -0.87 | -1.08 | -2.05 | -0.84 | 0.27 | -0.86 | Upgrade
|
| Cash Interest Paid | 9.52 | 5.61 | 4.6 | 4.9 | 5.18 | 2.62 | Upgrade
|
| Cash Income Tax Paid | 36.13 | 48.77 | 40.46 | 53.1 | 57.11 | -0.02 | Upgrade
|
| Levered Free Cash Flow | -270.2 | -359.3 | 381.75 | -44.2 | -788.38 | -118.8 | Upgrade
|
| Unlevered Free Cash Flow | -264.25 | -355.79 | 384.62 | -41.14 | -785.15 | -114.89 | Upgrade
|
| Change in Net Working Capital | 7.63 | 72.91 | -109.73 | -388.94 | 435.66 | -38.66 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.